349 related articles for article (PubMed ID: 11078223)
1. Activated microglial cells and complement factors are unrelated to cortical Lewy bodies.
Rozemuller AJ; Eikelenboom P; Theeuwes JW; Jansen Steur EN; de Vos RA
Acta Neuropathol; 2000 Dec; 100(6):701-8. PubMed ID: 11078223
[TBL] [Abstract][Full Text] [Related]
2. Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.
Mattila PM; Rinne JO; Helenius H; Dickson DW; Röyttä M
Acta Neuropathol; 2000 Sep; 100(3):285-90. PubMed ID: 10965798
[TBL] [Abstract][Full Text] [Related]
3. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
[TBL] [Abstract][Full Text] [Related]
4. Degeneration process of Lewy bodies in the brains of patients with dementia with Lewy bodies using alpha-synuclein-immunohistochemistry.
Iseki E; Marui W; Akiyama H; Uéda K; Kosaka K
Neurosci Lett; 2000 May; 286(1):69-73. PubMed ID: 10822155
[TBL] [Abstract][Full Text] [Related]
5. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.
Pletnikova O; West N; Lee MK; Rudow GL; Skolasky RL; Dawson TM; Marsh L; Troncoso JC
Neurobiol Aging; 2005; 26(8):1183-92. PubMed ID: 15917102
[TBL] [Abstract][Full Text] [Related]
6. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.
Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW
J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831
[TBL] [Abstract][Full Text] [Related]
7. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
[TBL] [Abstract][Full Text] [Related]
8. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
9. Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study.
Wakisaka Y; Furuta A; Tanizaki Y; Kiyohara Y; Iida M; Iwaki T
Acta Neuropathol; 2003 Oct; 106(4):374-82. PubMed ID: 12904992
[TBL] [Abstract][Full Text] [Related]
10. Glial involvement in the degeneration process of Lewy body-bearing neurons and the degradation process of Lewy bodies in brains of dementia with Lewy bodies.
Togo T; Iseki E; Marui W; Akiyama H; Uéda K; Kosaka K
J Neurol Sci; 2001 Feb; 184(1):71-5. PubMed ID: 11231035
[TBL] [Abstract][Full Text] [Related]
11. Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology.
Walker DG; Lue LF; Tang TM; Adler CH; Caviness JN; Sabbagh MN; Serrano GE; Sue LI; Beach TG
Neurobiol Aging; 2017 Jun; 54():175-186. PubMed ID: 28390825
[TBL] [Abstract][Full Text] [Related]
12. Lewy body-related alpha-synucleinopathy in the aged human brain.
Jellinger KA
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
[TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein-positive structures in association with diffuse neurofibrillary tangles with calcification.
Hishikawa N; Hashizume Y; Ujihira N; Okada Y; Yoshida M; Sobue G
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):280-7. PubMed ID: 12787325
[TBL] [Abstract][Full Text] [Related]
14. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
Marui W; Iseki E; Kato M; Akatsu H; Kosaka K
Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805
[TBL] [Abstract][Full Text] [Related]
15. Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia.
Bertrand E; Lechowicz W; Szpak GM; Lewandowska E; Dymecki J; Wierzba-Bobrowicz T
Folia Neuropathol; 2004; 42(3):141-50. PubMed ID: 15535032
[TBL] [Abstract][Full Text] [Related]
16. Lewy body-related alpha-synucleinopathy in aging.
Saito Y; Ruberu NN; Sawabe M; Arai T; Kazama H; Hosoi T; Yamanouchi H; Murayama S
J Neuropathol Exp Neurol; 2004 Jul; 63(7):742-9. PubMed ID: 15290899
[TBL] [Abstract][Full Text] [Related]
17. TIGAR inclusion pathology is specific for Lewy body diseases.
López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
[TBL] [Abstract][Full Text] [Related]
18. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
Iwatsubo T
Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
[TBL] [Abstract][Full Text] [Related]
19. A neuropathological study of the disturbance of the nigro-amygdaloid connections in brains from patients with dementia with Lewy bodies.
Iseki E; Kato M; Marui W; Uéda K; Kosaka K
J Neurol Sci; 2001 Apr; 185(2):129-34. PubMed ID: 11311294
[TBL] [Abstract][Full Text] [Related]
20. Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies.
Wetering JV; Geut H; Bol JJ; Galis Y; Timmermans E; Twisk JWR; Hepp DH; Morella ML; Pihlstrom L; Lemstra AW; Rozemuller AJM; Jonkman LE; van de Berg WDJ
Acta Neuropathol Commun; 2024 May; 12(1):73. PubMed ID: 38715119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]